Haemophilus influenzae B

Latest Headlines

Latest Headlines

Takeda's Hib vaccine gets Japanese approval

Almost 7 years after licensing it from Novartis, Takeda picked up a regulatory green light from Japan's Ministry of Health, Labour and Welfare for its Haemophilus influenzae type B (Hib) vaccine. The vaccine, Vaxem Hib, is approved for use in children aged two months to under 5 years.

Early shots do not cause celiac disease

In Sweden, between 1984 and 1996, there was a four-fold increase in cases of celiac disease, and the rates then fell as quickly as they rose. A team of Swedish researchers looked at medical records to unpack whether there really was a cause and effect between changes in the vaccination patterns and the spike in disease.

Sanofi's Hexaxim vax gets EMA thumbs up

The European Medicines Agency (EMA) has adopted a positive opinion for Sanofi Pasteur's hexavalent vaccine for babies and toddlers, Hexaxim, as part of a procedure designed to evaluate medicinal products intended for markets outside the European Union.

GSK's Nimenrix gets green light in Europe

GlaxoSmithKline's meningitis vaccine Nimenrix has been granted approval in Europe by the Committee for Medicinal Products for Human Use (CHMP).